Duffy & Partners proudly designed the brand identity and language for Wellmune for our client Biothera.
Wellmune is now featured as a immune health enhancing ingredient in a new brand of dairy products formulated for women. The new brand - Mia - is currently in test markets.
And in their latest news release, Biothera announced some amazing results on the impact of daily usage of Wellmune as a dietary supplement on the health impact of the common cold.
Here's the press release.
Wellmune WGP®, a natural immune-enhancing ingredient from Biothera, reduced the incidence of fever and eliminated the need for study subjects to miss work or school due to cold-like symptoms, researchers reported today at the 2008 Experimental Biology annual meeting.
Don Cox, Ph.D., Vice President of Research & Development for Biothera’s Healthcare Group, said, “This study’s results are exciting because they show the potential for Wellmune WGP to naturally enhance the body’s innate immune response to protect against and ameliorate the symptoms of something that every one of us encounters—the common cold. These results are consistent with numerous other immune health studies conducted with our ingredient, and indicate the real-life benefits that Wellmune WGP supplementation can provide.”
Douglas Kalman, Ph.D., RD, FACN, a director at Miami Research Associates, which conducted the study for Biothera, will present the research at the Poster Sessions starting 9:00 am on April 9th. (Study abstract.)
The double-blind, placebo-controlled study was conducted during the cold season with 40 healthy subjects, aged 18-65. The subjects were treated daily with either 250mg of Wellmune WGP or a placebo for 90 days. Wellmune WGP is a natural carbohydrate that activates key immune cells, including macrophages and neutrophils, to more quickly recognize and kill foreign challenges. The product engages the body’s natural defenses to promote health, wellness and vitality.
In contrast with the placebo group, study participants who received Wellmune WGP daily reported:
- No incidence of medically verified fever.
- An increase in general health markers, including physical energy and emotional well-being, as measured by a clinically validated health survey questionnaire (SF-36v-2).
- No need to take a “sick day” off of work or school (compared with 1.38 days of work/school missed for the placebo group).
In addition, although there were no differences between groups in the number of colds, at the end of the 12-week test period the Wellmune WGP-supplemented group exhibited significant improvements in Physical Component Summary scores as defined in the SF-36v-2 health survey.